When brain tumours occur (both primary and secondary brain tumours), components of the BBB will be modified to develop the blood-tumour barrier (BTB) [110], such as increased VEGF expression, loss of tight junctions and pericytes [111], and loss of basement membrane protein components [112]. This evidence concerns the gene VEGFA and brain neoplasm.